Clinical Trial Update: Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA

View source ↗

Summary

A completed Phase 3 trial evaluating dabigatran (Pradaxa) for prevention of venous thromboembolism after elective orthopedic surgery; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Thromboembolism | Status: COMPLETED | Results posted: 2014-01-16